Decellularized extracellular matrix materials for treatment of ischemic cardiomyopathy
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Ischemic cardiomyopathy (ICM) affect millions of patients globally. Decellularized extracellular matrix materials (dECM) have components, microstructure and mechanical properties similar to healthy cardiac tissues, and can be manufactured into various forms of implantable biomaterials including injectable hydrogels or epicardial patches, which have been extensively reported to attenuate pathological left ventricular remodeling and maintain heart function. Recently, dECM medical devices for ICM treatment have been approved for clinical use or studied in clinical trials, exhibiting considerable translation potential. Cells, growth factors and other bioactive agents have been incorporated with different dECM materials to improve the therapeutic outcomes. In addition, more detailed aspects of the biological effects and mechanisms of dECM treatment are being revealed. This review summarized recent advances in dECM materials from variable sources for cardiac repair, including extraction of extracellular matrix, cell integration, smart manufacturing of injectable hydrogels and cardiac patch materials, and their therapeutic applications. Besides, this review provides an outlook on the cutting-edge development directions in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036 · cited 1×
“Ischemic cardiomyopathy (ICM) remain one of the leading causes of death worldwide over the past few decades [1 – 3], opposing heavy medical and financial burdens on patients and community.”
BackgroundAngiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957 · cited 1×
“Drugs including angiotensin receptor-neurolysin inhibitors, β -blockers, angiotensin-converting enzyme inhibitors, and mineralocorticoid-receptor antagonists reduce the influence of the mechanical drives for HF, but do not eliminate the latter [18 – 20].”
BackgroundHeart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784 · cited 1×
“Ischemic cardiomyopathy (ICM) remain one of the leading causes of death worldwide over the past few decades [1 – 3], opposing heavy medical and financial burdens on patients and community.”
BackgroundAn overview of tissue and whole organ decellularization processes
Crapo, P. M., Gilbert, T. W., & Badylak, S. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.057 · Cited by 3,591
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Advances in engineering hydrogels
Zhang, Y. S., & Khademhosseini, A. (2017) · Science · doi:10.1126/science.aaf3627 · Cited by 2,908 · cited 1×
“Together with some of these bioactivities, biomaterials that carry cells could extend cell retention, and better maintain their activity [44,45].”
BackgroundPerfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650 · cited 1×
“In 2008, Ott et al. generated the first acellular rat whole heart (WH) through coronary perfusion on a modified Langendorff apparatus, using a chemical solution containing 1 % SDS and 1 % Triton X-100 [95].”
MethodPrinting three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904
Hinton, T. J., Jallerat, Q., Palchesko, R. N., Park, J. H., Grodzicki, M. S., Shue, H.-J., Ramadan, M. H., Hudson, A. R., & Feinberg, A. W. (2015) · Science Advances · doi:10.1126/sciadv.1500758 · Cited by 1,805
Extracellular matrix as a biological scaffold material: Structure and function
BADYLAK, S., FREYTES, D., & GILBERT, T. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.09.013 · Cited by 1,671
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596 · cited 1×
“Necrotic myocardium is gradually replaced with fibrotic scar tissue, which leads to reduced myocardium contractility and cardiac function, and heart failure (HF) at end stage [12 – 14].”
BackgroundRevisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 1×
“Cardiac wall consists of three layers: the innermost endocardium, the myocardium, and the outer pericardium [78].”
BackgroundBadylak, S. F., Taylor, D., & Uygun, K. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124743 · Cited by 1,041 · cited 1×
“Type I collagen is the main structural component of the cardiac interstitium, accounting for more than 85 % of the collagen matrix, type III collagen accounts for less than 11 %, and type IV, V, VI and VIII collagen accounts for about 4 % [82,83].”
BackgroundInstrumented cardiac microphysiological devices via multimaterial three-dimensional printing
Lind, J. U., Busbee, T. A., Valentine, A. D., Pasqualini, F. S., Yuan, H., Yadid, M., Park, S.-J., Kotikian, A., Nesmith, A. P., Campbell, P. H., et al. (2017) · Nature Materials · doi:10.1038/nmat4782 · Cited by 863
Extracellular matrix-based materials for regenerative medicine
Hussey, G. S., Dziki, J. L., & Badylak, S. F. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0023-x · Cited by 844
Regeneration and experimental orthotopic transplantation of a bioengineered kidney
Song, J. J., Guyette, J. P., Gilpin, S. E., Gonzalez, G., Vacanti, J. P., & Ott, H. C. (2013) · Nature Medicine · doi:10.1038/nm.3154 · Cited by 793 · cited 1×
“Kidney dECM (kECM) can be extracted by enzyme digestion or SDS treatment [110,111].”
MethodZhang, X., Chen, X., Hong, H., Hu, R., Liu, J., & Liu, C. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.09.014 · Cited by 680
Self-citationJang, J., Park, H.-J., Kim, S.-W., Kim, H., Park, J. Y., Na, S. J., Kim, H. J., Park, M. N., Choi, S. H., Park, S. H., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.026 · Cited by 673 · cited 3×
“6C) [196]. hdECM reca-pitulated cardiac tissue specific microenvironments and significantly enhanced the maturation of cells and generation of microvascular-like tissue in vitro .”
BackgroundOrgan engineering based on decellularized matrix scaffolds
Song, J. J., & Ott, H. C. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.005 · Cited by 501 · cited 2×
“Common sterilization methods for medical devices, including pressurized steam, dry heat, irradiation or ethylene oxide, compromise the mechanical properties of dECM materials and denature their proteins [294].”
BackgroundHinderer, S., Layland, S. L., & Schenke-Layland, K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.019 · Cited by 469 · cited 3×
“Injectable hydrogels can be delivered to myocardium in a multi-point fashion via a minimally invasive transendocardial catheter system [46].”
BackgroundRieder, E., Kasimir, M.-T., Silberhumer, G., Seebacher, G., Wolner, E., Simon, P., & Weigel, G. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.06.017 · Cited by 430 · cited 1×
“The residual SDS in dECM causes cytotoxicity during recellularization in certain applications [125].”
BackgroundShadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N. (2017) · Nature Communications · doi:10.1038/s41467-017-01946-x · Cited by 420 · cited 1×
“Necrotic myocardium is gradually replaced with fibrotic scar tissue, which leads to reduced myocardium contractility and cardiac function, and heart failure (HF) at end stage [12 – 14].”
BackgroundFlexible shape-memory scaffold for minimally invasive delivery of functional tissues
Montgomery, M., Ahadian, S., Davenport Huyer, L., Lo Rito, M., Civitarese, R. A., Vanderlaan, R. D., Wu, J., Reis, L. A., Momen, A., Akbari, S., et al. (2017) · Nature Materials · doi:10.1038/nmat4956 · Cited by 409
Matrix-bound nanovesicles within ECM bioscaffolds
Huleihel, L., Hussey, G. S., Naranjo, J. D., Zhang, L., Dziki, J. L., Turner, N. J., Stolz, D. B., & Badylak, S. F. (2016) · Science Advances · doi:10.1126/sciadv.1600502 · Cited by 387 · cited 1×
“…is derived from organs/tissues by removing the cells and desirably the immunogenic components, while maintaining the majority of the structural components and part of the bioactive components (including collagens, glycosaminoglycans (GAGs), proteoglycans, and matrix-bound nanovesicles) [68,69].”
BackgroundSelf-citationBiomimetic 3D tissue printing for soft tissue regeneration
Pati, F., Ha, D.-H., Jang, J., Han, H. H., Rhie, J.-W., & Cho, D.-W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.043 · Cited by 368
Bioengineering human myocardium on native extracellular matrix
Guyette, J. P., Charest, J. M., Mills, R. W., Jank, B. J., Moser, P. T., Gilpin, S. E., Gershlak, J. R., Okamoto, T., Gonzalez, G., Milan, D. J., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.306874 · Cited by 343 · cited 1×
“Then, the ischemic myocardium undergoes ECM remodeling and gradually loses its original structure and contractile function [87].”
Background3D cell printing of functional skeletal muscle constructs using skeletal muscle-derived bioink
Choi, Y., Kim, T. G., Jeong, J., Yi, H., Park, J. W., Hwang, W., & Cho, D. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600483 · Cited by 298 · cited 1×
“Accordingly, 1 – 2% is the optimized dECM concentration balancing pros and cons [196,244].”
BackgroundBrown, M., Li, J., Moraes, C., Tabrizian, M., & Li-Jessen, N. Y. K. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121786 · Cited by 282
Bejleri, D., Streeter, B. W., Nachlas, A. L. Y., Brown, M. E., Gaetani, R., Christman, K. L., & Davis, M. E. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800672 · Cited by 255 · cited 2×
“Bejleri et al. bioprinted a cardiac patch composed of GelMA and cardiac dECM with encapsulated human cardiac progenitor cells (hCPC) at low temperature, which was crosslinked via white light polymerization and 37 ◦ C bath [195].”
BackgroundMethodDecellularization for whole organ bioengineering
Arenas-Herrera, J. E., Ko, I. K., Atala, A., & Yoo, J. J. (2013) · Biomedical Materials · doi:10.1088/1748-6041/8/1/014106 · Cited by 221
Injectable and conductive cardiac patches repair infarcted myocardium in rats and minipigs
Wang, L., Liu, Y., Ye, G., He, Y., Li, B., Guan, Y., Gong, B., Mequanint, K., Xing, M. M. Q., & Qiu, X. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00796-9 · Cited by 207
Challenges and opportunities for the next generation of cardiovascular tissue engineering
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022) · Nature Methods · doi:10.1038/s41592-022-01591-3 · Cited by 176 · cited 2×
“To achieve better myocardial restoration, researchers have combined cells, growth factors and nuclei acids with dECM to mimic physiological ECM [73].”
BackgroundMethodDas, S., Kim, S.-W., Choi, Y.-J., Lee, S., Lee, S.-H., Kong, J.-S., Park, H.-J., Cho, D.-W., & Jang, J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.04.026 · Cited by 150
Wang, Y., Bao, J., Wu, Q., Zhou, Y., Li, Y., Wu, X., Shi, Y., Li, L., & Bu, H. (2015) · Xenotransplantation · doi:10.1111/xen.12141 · Cited by 125 · cited 2×
“Liver dECM (liECM) are usually obtained through a combination of freeze-thawing, detergents and enzymes [106 – 109].”
MethodInfluentialDecellularized Extracellular Matrix for Remodeling Bioengineering Organoid's Microenvironment
Zhu, L., Yuhan, J., Yu, H., Zhang, B., Huang, K., & Zhu, L. (2023) · Small · doi:10.1002/smll.202207752 · Cited by 123 · cited 1×
“Although there is no industrial standard to identify DNA removal efficiency [92], some basic requirements have been proposed: 1) safe amount ( ≤ 50 ng dsDNA/mg dry ECM), 2) DNA fragments shorter than 200 dp, thus not activating inflammation, 3) no visible nuclear in hematoxylin-eosin staining or 4…”
BackgroundBiocompatibility of Acellular Human Pericardium
Mirsadraee, S., Wilcox, H. E., Watterson, K. G., Kearney, J. N., Hunt, J., Fisher, J., & Ingham, E. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.01.026 · Cited by 104
Cao, G., Huang, Y., Li, K., Fan, Y., Xie, H., & Li, X. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00530g · Cited by 101 · cited 1×
“To date, SIS has been widely studied and successfully translated into commercial products approved by FDA [185].”
BackgroundZhuang, R. Z., Lock, R., Liu, B., & Vunjak-Novakovic, G. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00885-3 · Cited by 84 · cited 1×
“Novel biomaterials have been developed to mediate the pathological mechanical environment and/or increase the efficiency of cell transplantation [25 – 38].”
BackgroundBeachley, V., Ma, G., Papadimitriou, C., Gibson, M., Corvelli, M., & Elisseeff, J. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36218 · Cited by 72
Directing the growth and alignment of biliary epithelium within extracellular matrix hydrogels
Lewis, P. L., Yan, M., Su, J., & Shah, R. N. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.039 · Cited by 61 · cited 1×
“Adding sacrificial Pluronic F-127 to dECM solution can increase the viscosity of bioink and provide mechanical support for the constructs [245,246].”
MethodDecellularized xenografts in regenerative medicine: From processing to clinical application
Capella‐Monsonís, H., & Zeugolis, D. I. (2021) · Xenotransplantation · doi:10.1111/xen.12683 · Cited by 57 · cited 1×
“…have been developed to isolate tissue-specific ECM, including chemical treatments (e.g. acids and al-kalis, detergents, and alcohols), biological reactions (e.g. enzymes, chelating agents) and physical degradation (e.g. pressure, mechanical, freeze-thaw, and electroporation), etc [75,89 – 93].”
BackgroundEffect of decellularized tissue powders on a rat model of acute myocardial infarction
Tabuchi, M., Negishi, J., Yamashita, A., Higami, T., Kishida, A., & Funamoto, S. (2015) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.07.010 · Cited by 31 · cited 2×
“Tabuchi et al. fractured dECM into powders with size below 500 μ m [162].”
Background
Cited by
Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective
Razavi, Z.-S., Soltani, M., Mahmoudvand, G., Farokhi, S., Karimi-Rouzbahani, A., Farasati-Far, B., Tahmasebi-Ghorabi, S., Pazoki-Toroudi, H., & Afkhami, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1385124 · Cited by 64
New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Farokhi, S., Razavi, Z.-S., Mavaei, M., Shadab, A., Afkhami, H., & Sardarabadi, H. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06113-8 · Cited by 27
Xu, Z.-Y., Wang, M., Shi, J.-Y., Liu, Y., Yu, C., Zhang, X.-Y., Zhang, C.-W., He, Q.-F., Pan, C., Zhou, J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101700 · Cited by 5
“Recently, there has been a surge in reports on the impact of the mechanical properties of the extracellular matrix (ECM) on cancer cell progression and stem cell regulation [17,18].”
Self-citation
Metadata
- Authors
- Liu, W., Zhang, X., Jiang, X., Dai, B., Zhang, L., & Zhu, Y.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 33
- Pages
- 460-482
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W4389145750
- Cited by
- 43
- References
- 43
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.